Related Experiment Video
Updated: May 7, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Selection and adaptation during metastatic cancer progression
1Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany. christoph.klein@ukr.de
Disseminated cancer cells show significant genomic differences before metastasis. This suggests they need further evolution to become fully malignant, impacting cancer diagnosis and treatment strategies.
Area of Science:
- Oncology
- Cancer Biology
- Genomics
Background:
- Cancer evolution is typically viewed as asexual, driven by genomic instability within or near the primary tumor.
- Disseminated cancer cells (DCCs) surviving surgery present a unique model for studying early-stage cancer evolution.
- Understanding DCCs is crucial for developing effective adjuvant therapies and improving patient outcomes.
Purpose of the Study:
- To investigate the genomic heterogeneity of disseminated cancer cells post-surgery.
- To understand the evolutionary trajectory of DCCs before metastatic manifestation.
- To identify potential therapeutic targets and diagnostic strategies based on DCC characteristics.
Main Methods:
- Genomic analysis of disseminated cancer cells.
- Comparative analysis of heterogeneity within primary tumors versus DCCs.
- Longitudinal study of clonal expansion and selection in DCCs.
Main Results:
- Disseminated cancer cells exhibit extreme genomic heterogeneity prior to metastasis.
- This heterogeneity is subsequently reduced through selective clonal expansion.
- The findings suggest DCCs lack key malignant traits initially.
Conclusions:
- Cancer evolution in disseminated cells differs from traditional models.
- Early-stage DCCs possess unique genomic landscapes requiring further adaptation for metastasis.
- Targeting these evolutionary steps offers new avenues for adjuvant cancer therapy and diagnostics.
More Related Videos
07:44Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
09:44Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Selectins
Targeted Cancer Therapies
There are several types of targeted therapies against specific...